The Long-term Effect of Acupuncture for Migraine Prophylaxis: A Randomized Clinical Trial

Migraine is one of the most disabling neurologic disorders worldwide, affecting about 15% of the population in the United States and up to 12% of the Asian population. This condition causes intense, throbbing headaches, often accompanied by nausea and sensitivity to light or sound. Preventive treatment is necessary for approximately one quarter of migraine patients, but conventional medications such as divalproex sodium, topiramate, metoprolol, and propranolol can cause significant side effects, including weight gain, fatigue, sleep disturbances, and gastrointestinal problems. Faced with these limitations, many patients and clinicians look for safer and more effective alternatives.

Acupuncture has been widely used to treat migraine in both China and Western countries, especially for patients who do not respond well to conventional medications. Although prior studies have shown mixed results regarding the efficacy of true acupuncture compared with sham acupuncture, one fundamental question remained unanswered: whether true acupuncture is superior to sham in preventing future migraine attacks over time. This research was designed to address that question through a rigorous, long-duration study.

The study was a randomized controlled trial conducted over 24 weeks at three medical centers in China between October 2012 and September 2014. The investigators recruited 249 participants aged 18 to 65 years who suffered from migraine without aura, a specific form of migraine that does not include neurologic symptoms such as visual disturbances or sensory changes that precede the headache. Selected patients had 2 to 8 migraine attacks per month and were randomly assigned to three groups: true acupuncture, sham acupuncture, or waiting list. The first two groups received 20 electroacupuncture sessions over 4 weeks, while the waiting list group received no treatment during the study period.

The primary outcome was the change in migraine attack frequency between baseline and week 16, with patients keeping detailed attack diaries throughout the period.

The results demonstrated clear and lasting benefits of true acupuncture. At week 16 after treatment initiation, the true acupuncture group had a mean reduction of 3.2 migraine attacks per month, compared with 2.1 attacks in the sham acupuncture group and only 1.4 attacks in the waiting list group. The difference between true and sham acupuncture was statistically significant, with an additional reduction of 1.1 attacks per month. Even more important, true acupuncture showed persistent superiority over the waiting list group, with a difference of 1.8 fewer attacks per month.

The benefits of true acupuncture remained consistent throughout the entire 24-week follow-up period, including reductions in days with migraine, pain intensity, and use of acute medications. Patients who received true acupuncture also showed improvements in migraine-related emotional quality of life.

For patients with migraine, these results offer real hope of an effective and safe preventive treatment option. True acupuncture proved superior both to sham acupuncture and to no treatment, providing benefits that persisted for at least 20 weeks after the end of treatment sessions. This is particularly important because it means that a relatively brief course of treatment can offer prolonged relief. For clinicians, the study provides robust evidence that acupuncture can be considered a legitimate preventive treatment option for patients with migraine without aura, especially those who experience unacceptable side effects with conventional medications or prefer non-pharmacologic approaches.

The safety profile of acupuncture was excellent, with only mild and transient adverse events reported by some participants.

The study has several important limitations. First, a semi-standardized acupoint prescription was used instead of fully personalized treatment that an experienced acupuncturist could develop for each patient. Second, the waiting list group could not be blinded to its assignment, which may have influenced results through psychological factors. Third, and perhaps most important for clinical practice, the study did not compare acupuncture with standard preventive medications for migraine, leaving an important question about relative efficacy unanswered.

Despite these limitations, the research represents one of the largest and most rigorous evaluations of acupuncture for migraine prevention to date, providing compelling evidence that true acupuncture can deliver lasting and clinically meaningful benefits for patients with migraine without aura, justifying its consideration as a valid therapeutic option among available preventive treatments.